Phase I-II
A Phase 1/2a Study of Bria-PROS+ Cellular Immunotherapy in Metastatic Prostate Cancer
- Study IRB#:2000043724
- Last Updated:11/16/2026
To evaluate the safety of Bria-PROS+ cellular immunotherapy in patients with advanced prostate cancer
Contact Us
For more information about this study, including how to volunteer, contact:
Jialing Zhang
- Phone Number: 203-737-8884
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877-978-8343 for more information.
Study Location
- Yale University